Contribution By Pankaj Singh
Pizza Hut, a quick-service restaurant (QSR), has reportedly collaborated with HUL (Hindustan Unilever) to add the company’s Kwality Wall’s desserts and ice cream to its delivery, take-away as well as dine-in menu.
With this alliance, Piz
Ultrahuman, a health and fitness platform, has reportedly secured $17.5 million in a Series B funding, bringing the total funds raised by the company to $25 million to date.
The latest funding round was initiated by investors namely Blume Ventures,
Saudi Aramco has reportedly held advanced talks for an all-stock deal to obtain a stake in the chemicals and oil refining business of Reliance Industries Ltd., according to a subject matter expert.
The oil giant is negotiating the purchase of around
InnoCare Pharma Ltd., a biopharma company emphasizing on drug innovation for autoimmune diseases and cancer, has reportedly announced that the first subject dosed in novel TYK2 (Tyrosine Kinase 2) inhibitors ICP-332’s clinical trial in China.
U.S. oil giant Chevron Corp. along with Exxon Mobil Corp. has reportedly planned to bulk up in the expanding renewable fuels sector, by searching for methods to create such products at current facilities.
The two biggest oil companies in the United
American international fast food restaurant chain Wendy’s has reportedly announced that it will open around 700 ghost kitchens throughout the United States, Canada, and the United Kingdom by 2025, by partnering with startup Reef Technology.
Recurrent Energy LLC, a fully-owned subsidiary of Canadian Solar Inc., has reportedly announced a Resource Adequacy agreement for a 15-year period with Pacific Gas & Electric to offer 600MWh/150MW of energy storage in the second phase of the Crim
TytoCare Ltd., the first all-around examination platform and modular device for on-demand, AI-powered, remote medical examinations, has reportedly expanded its integration with Epic’s MyChart allowing for seamless asynchronous workflow.
Epizyme Inc., a commercial-stage, fully integrated biopharmaceutical company developing and providing advanced epigenetic therapies, and HUTCHMED Ltd. have reportedly announced a partnership to research, manufacture, develop, and promote TAZVERIK®